TheProfitWatch

CLDX - Celldex Therapeutics, Inc

Day 1m 10m 60m PreMarket Market AfterHours Gap
26.29 1.06 (4.03%) --- --- --- 0.0 (0.0%) 1.14 (4.35%) --- 0.0 (0.0%)

Celldex Therapeutics Inc is a biopharmaceutical company. It is focused on the development and commercialization of several immunotherapy technologies and other cancer-targeting biologics. The company is also engaged in clinical trials for products targeting breast cancer, metastatic melanoma, lung cancer, solid tumors, and ovarian cancer. It has single operating and reportable segment that operates in the business of development, manufacturing and commercialization of novel therapeutics for human health care.

Category: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES
Market Period: Closed

Earnings & Ratios

Basic EPS:
-0.85
Diluted EPS:
-0.85
Basic P/E:
-32.1765
Diluted P/E:
-32.1765
RSI(14) 1m:
77.42
VWAP:
27.33
RVol:
0.734

Events

Period Kind Movement Occurred At
1m Price increase 1m 26.59 +0.38 (+1.43%) Oct 15 09:30

Related News